Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Ritlecitinib is an effective new treatment for Alopecia Areata.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

RTA 408 cream protects mice from radiation skin damage.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Rothmund-Thomson syndrome type 2 can cause chronic, poorly healing wounds.

An 11-year-old girl with a rare skin disorder also had cornea issues and dry eye, needing careful management.

ATP6AP1‐CDG can cause hearing loss, hair loss, and protein issues, even in female carriers.

A rare case of trichothiodystrophy was found with autism, seizures, and mental retardation.